لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Longo F; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, 28034, Spain., Jorge M; Hospital Álvaro Cunqueiro, Vigo (Pontevedra), 36213, Spain., Yaya R; Instituto Valenciano de Oncología (IVO), Valencia, 46009, Spain., Montes AF; Complexo Universitario Hospitalario de Ourense, 32005, Spain., Lago NM; Complejo Hospitalario Universitario, A Coruña, 15006, Spain., Brozos E; Complejo Hospitalario Universitario de Santiago, Santiago de Compostela (La Coruña), 15706, Spain., Aparicio J; Hospital Universitario y Politécnico La Fe, Valencia, 46026, Spain., Quintero G; Hospital Universitario Lucus Augusti, Lugo, 27003, Spain., Ceballos E; Hospital San Pedro de Alcántara, Cáceres, 10003, Spain., Buxó E; Hospital Quirón Salud, Barcelona, 08023, Spain., Lopez AM; Hospital Universitario de Burgos, 09006, Spain., Pellón ML; Complexo Universitario Hospitalario de El Ferrol (La Coruña), 15405, Spain., Molina R; Hospital Universitario Príncipe de Asturias, Alcalá de Henares (Madrid), 28805, Spain., Diaz-Paniagua L; Hospital Universitario de Getafe (Madrid), 28905, Spain., Cerdà P; Centro Médico Teknon, Barcelona, 08022, Spain., Leiva PL; Complejo Hospitalario de Jaén, 23007, Spain., Carnicero AM; Hospital de San Pedro, Logroño, 26006, Spain., Cousillas A; Complexo Universitario Hospitalario de Pontevedra, 36071, Spain., Paris L; Centro Oncológico de Galicia, La Coruña, 15009, Spain., García-Paredes B; Hospital Clínico San Carlos, Madrid, 28040, Spain., Romero C; Hospital POVISA, Vigo (Pontevedra), 36201, Spain., Ortega M; Department of Medical, Lilly, Madrid, 28108, Spain., Molero A; Department of Medical, Lilly, Madrid, 28108, Spain., la Torre S; Department of Medical, Lilly, Madrid, 28108, Spain., Jen MH; European Statistics Group, Lilly, Surrey, GU206PH, UK., Díaz-Cerezo S; Department of Medical, Lilly, Madrid, 28108, Spain.

المصدر: Future oncology (London, England) [Future Oncol] 2021 May; Vol. 17 (14), pp. 1777-1791. Date of Electronic Publication: 2021 Feb 16.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*therapy , Antibodies, Monoclonal, Humanized/*administration & dosage , Paclitaxel/*administration & dosage , Stomach Neoplasms/*therapy, Adenocarcinoma/diagnosis ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Chemotherapy, Adjuvant/methods ; Chemotherapy, Adjuvant/statistics & numerical data ; Esophagogastric Junction/pathology ; Esophagogastric Junction/surgery ; Female ; Gastrectomy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy/methods ; Neoadjuvant Therapy/statistics & numerical data ; Paclitaxel/adverse effects ; Progression-Free Survival ; Retrospective Studies ; Spain/epidemiology ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Ramucirumab

المؤلفون: Cueva JF; Oncology Department, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain. jfcueva@gmail.com., Antolín S; Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Calvo L; Oncology Department, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Fernández I; Oncology Department, Complejo Hospitalario Universitario Vigo, Vigo, Spain., Ramos M; Oncology Department, Centro Oncológico Galicia, A Coruña, Spain., de Paz L; Oncology Department, Complejo Hospitalario Universitario Ferrol, Ferrol, Spain., Mata JG; Oncology Department, Complejo Hospitalario Universitario Ourense, Orense, Spain., López R; Oncology Department, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain., Constenla M; Oncology Department, Complejo Hospitalario Universitario Pontevedra, Pontevedra, Spain., Pérez E; Oncology Department, Complejo Hospitalario Universitario Ourense, Orense, Spain., González A; Oncology Department, Centro Oncológico Galicia, A Coruña, Spain., Pellón ML; Oncology Department, Complejo Hospitalario Universitario Ferrol, Ferrol, Spain., Varela S; Oncology Department, Complejo Hospitalario Universitario Lugo, Lugo, Spain., López T; Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2017 Sep; Vol. 19 (9), pp. 1067-1078. Date of Electronic Publication: 2017 Mar 24.

نوع المنشور: Consensus Development Conference; Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Breast Neoplasms/*drug therapy , Cardiotoxicity/*prevention & control, Cardiotoxicity/etiology ; Female ; Humans ; Risk Factors

المؤلفون: Salgado M; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, 32005 Ourense, Spain. Mercedes.Salgado.Fernandez@sergas.es., Reboredo M, Mendez JC, Quintero G, Pellón ML, Romero C, Jorge M, Montes AF, Valladares-Ayerbes M, Ramos M, Varela S, Alonso MÁ

مؤلفون مشاركون: Grupo Gallego De Investigaciones Oncológicas

المصدر: Anticancer research [Anticancer Res] 2013 Sep; Vol. 33 (9), pp. 4089-96.

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Capecitabine ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/analogs & derivatives ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Gemcitabine